ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Articles
A Review of Testosterone CV Studies Based on Prescription Data
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Excel Male" data-source="post: 272823" data-attributes="member: 1"><p>Another paper in the Asian Review of Andrology reviews the studies of cardiovascular events that were based on analyzing prescription records. Each study is summarized and its weaknesses discussed. The conclusion is that most studies have found no link between TRT and cardiovascular events.</p><p></p><p></p><p></p><p>In large database studies that included over 215 000 T-treated men, most studies did not find that T treatment was associated with increased risks for mortality or for MI, stroke, or thrombosis. However, given the limitations of observational data, the cardiovascular risks of T treatment will remain unclear until a large, prospective, randomized, double-blind, placebo-controlled trial is conducted that is specifically designed to examine the risk for CV events with T treatment. Until then, clinicians should follow established clinical guidelines for T replacement and review potential risks of treatment with patients, recognizing that risks might be greatest in the first several months after initiation of testosterone therapy.</p><p></p><p></p><p></p><p><a href="http://www.ajandrology.com/preprintarticle.asp?id=212903" target="_blank">Full text</a> of the article is online.</p></blockquote><p></p>
[QUOTE="Excel Male, post: 272823, member: 1"] Another paper in the Asian Review of Andrology reviews the studies of cardiovascular events that were based on analyzing prescription records. Each study is summarized and its weaknesses discussed. The conclusion is that most studies have found no link between TRT and cardiovascular events. In large database studies that included over 215 000 T-treated men, most studies did not find that T treatment was associated with increased risks for mortality or for MI, stroke, or thrombosis. However, given the limitations of observational data, the cardiovascular risks of T treatment will remain unclear until a large, prospective, randomized, double-blind, placebo-controlled trial is conducted that is specifically designed to examine the risk for CV events with T treatment. Until then, clinicians should follow established clinical guidelines for T replacement and review potential risks of treatment with patients, recognizing that risks might be greatest in the first several months after initiation of testosterone therapy. [url=http://www.ajandrology.com/preprintarticle.asp?id=212903]Full text[/url] of the article is online. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Articles
A Review of Testosterone CV Studies Based on Prescription Data
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top